Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4001
PUT
Ultra Clean Holdings
UCTT
$2.31B
| $211K | ﹤0.01% |
2,600
+400
| +18% | +$33.4K |
2026 Q2
1 quarter
|
|
4002
Larimar Therapeutics
LRMR
$280M
| $211K | ﹤0.01% |
65,893
-47,581
| -42% | -$184K |
2026 Q2
1 quarter
|
|
4003
Tootsie Roll Industries
TR
$2.84B
| $210K | ﹤0.01% |
5,601
-58,729
| -91% | -$2.3M |
2026 Q2
1 quarter
|
|
4004
Omega Flex
OFLX
$237M
| $210K | ﹤0.01% |
+8,270
| New | +$233K |
2026 Q3
0 quarters
|
|
4005
Tonix Pharmaceuticals
TNXP
$63M
| $210K | ﹤0.01% |
+21,530
| New | +$254K |
2026 Q3
0 quarters
|
|
4006
i-80 Gold Corp
IAUX
$1.12B
| $210K | ﹤0.01% |
126,311
-1,786
| -1% | -$2.85K |
2025 Q2
5 quarters
|
|
4007
Aquestive Therapeutics
AQST
$449M
| $210K | ﹤0.01% |
45,260
-25,162
| -36% | -$112K |
2026 Q1
2 quarters
|
|
4008
Protara Therapeutics
TARA
$150M
| $209K | ﹤0.01% |
68,685
+50,561
| +279% | +$197K |
2026 Q2
1 quarter
|
|
4009
CALL
Canadian Imperial Bank of Commerce
CM
$105B
| $209K | ﹤0.01% |
1,900
-47,100
| -96% | -$5.5M |
2026 Q1
2 quarters
|
|
4010
CALL
Joby Aviation
JOBY
$5.43B
| $209K | ﹤0.01% |
34,600
-500
| -1% | -$3.63K |
2025 Q3
4 quarters
|
|
4011
CALL
PACCAR
PCAR
$56B
| $209K | ﹤0.01% |
+1,900
| New | +$238K |
2026 Q3
0 quarters
|
|
4012
CALL
Old Dominion Freight Line
ODFL
$35.4B
| $209K | ﹤0.01% |
1,200
-9,600
| -89% | -$1.96M |
2026 Q1
2 quarters
|
|
4013
Ready Capital
RC
$146M
| $208K | ﹤0.01% |
179,731
-50,666
| -22% | -$82.9K |
2023 Q3
12 quarters
|
|
4014
CALL
Global X Cybersecurity ETF
BUG
$2.06B
| $208K | ﹤0.01% |
+4,500
| New | +$187K |
2026 Q3
0 quarters
|
|
4015
Carlisle Companies
CSL
$15.2B
| $207K | ﹤0.01% |
644
-47,035
| -99% | -$16.3M |
2026 Q1
2 quarters
|
|
4016
Ranpak Holdings
PACK
$297M
| $207K | ﹤0.01% |
49,861
-30,185
| -38% | -$161K |
2026 Q2
1 quarter
|
|
4017
iShares Short-Term National Muni Bond ETF
SUB
$13.3B
| $206K | ﹤0.01% |
+1,975
| New | +$209K |
2026 Q3
0 quarters
|
|
4018
BuzzFeed
BZFD
$42.3M
| $206K | ﹤0.01% |
182,543
+106,588
| +140% | +$127K |
2026 Q2
1 quarter
|
|
4019
CALL
CDW
CDW
$21.6B
| $205K | ﹤0.01% |
1,600
-1,700
| -52% | -$240K |
2026 Q2
1 quarter
|
|
4020
CALL
Levi Strauss
LEVI
$9.22B
| $205K | ﹤0.01% |
10,400
-56,200
| -84% | -$1.26M |
2025 Q3
4 quarters
|
|
4021
CALL
iShares MSCI Japan ETF
EWJ
$23.3B
| $205K | ﹤0.01% |
2,100
-78,100
| -97% | -$7.43M |
2023 Q4
11 quarters
|
|
4022
Credo Technology Group
CRDO
$26.3B
| $203K | ﹤0.01% |
1,043
-123,133
| -99% | -$26.5M |
2025 Q1
6 quarters
|
|
4023
RPC Inc
RES
$1.25B
| $203K | ﹤0.01% |
+36,052
| New | +$216K |
2026 Q3
0 quarters
|
|
4024
Annaly Capital Management
NLY
$13.8B
| $202K | ﹤0.01% |
10,719
-7,758
| -42% | -$174K |
2026 Q2
1 quarter
|
|
4025
Loma Negra
LOMA
$1.01B
| $202K | ﹤0.01% |
+21,990
| New | +$229K |
2026 Q3
0 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.